First Trust Advisors LP Cuts Stake in Aetna Inc. (AET)
First Trust Advisors LP lessened its holdings in Aetna Inc. (NYSE:AET) by 2.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,030 shares of the company’s stock after selling 4,238 shares during the quarter. First Trust Advisors LP owned 0.05% of Aetna worth $27,036,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Bruderman Asset Management LLC bought a new stake in shares of Aetna in the second quarter worth $106,000. Liberty Capital Management Inc. lifted its position in shares of Aetna by 206.9% in the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after purchasing an additional 629 shares in the last quarter. Guardian Life Insurance Co. of America lifted its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after purchasing an additional 9 shares in the last quarter. Westside Investment Management Inc. lifted its position in shares of Aetna by 53.5% in the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after purchasing an additional 400 shares in the last quarter. Finally, Phocas Financial Corp. bought a new stake in shares of Aetna in the second quarter worth $182,000. 89.45% of the stock is currently owned by institutional investors and hedge funds.
In other Aetna news, President Karen S. Lynch sold 15,271 shares of Aetna stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares of the company’s stock, valued at approximately $10,404,498.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Margaret M. Mccarthy sold 10,288 shares of Aetna stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.
Shares of Aetna Inc. (NYSE:AET) opened at 170.03 on Wednesday. The company has a market cap of $56.47 billion, a PE ratio of 37.74 and a beta of 0.53. The company’s 50-day moving average is $159.75 and its 200 day moving average is $152.04. Aetna Inc. has a 52-week low of $104.59 and a 52-week high of $184.98.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.07 by $0.38. The business had revenue of $14.99 billion during the quarter, compared to analyst estimates of $15.12 billion. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The company’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.07 EPS. On average, analysts anticipate that Aetna Inc. will post $9.50 EPS for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.18%. The ex-dividend date of this dividend was Wednesday, October 11th. Aetna’s payout ratio is presently 43.67%.
A number of analysts have recently commented on the stock. Zacks Investment Research lowered shares of Aetna from a “buy” rating to a “hold” rating in a research report on Tuesday, October 24th. Cantor Fitzgerald reissued an “overweight” rating and issued a $175.00 price objective (up previously from $150.00) on shares of Aetna in a research report on Wednesday, August 9th. Jefferies Group LLC reissued a “hold” rating and issued a $163.00 price objective (up previously from $157.00) on shares of Aetna in a research report on Friday, August 4th. Deutsche Bank AG boosted their price objective on shares of Aetna from $157.00 to $163.00 and gave the stock a “hold” rating in a research report on Monday, August 7th. Finally, Royal Bank Of Canada boosted their price objective on shares of Aetna from $162.00 to $171.00 and gave the stock an “outperform” rating in a research report on Friday, August 4th. Nine analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the stock. Aetna currently has a consensus rating of “Buy” and an average price target of $163.67.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.